Pharmaceutical compositions

• US 4,689,219 A
• Filed: 06/07/1984
• Issued: 08/25/1987
• Est. Priority Date: 06/29/1983
• Status: Expired due to Fees

• Current Assignee: Reckitt & Colman Products Limited (Reckitt Benckiser Group PLC)
• Original Assignee: Reckitt & Colman Products Limited (Reckitt Benckiser Group PLC)
• Inventors: Sugden, Keith
• Primary Examiner(s): WADDELL, FREDERICK
• Application Number:
  US06/618,239
• Time in Patent Office: 1,174 Days
• Field of Search: 514/54, 514/2, 514/886, 424/80
• US Class Current: 514/54
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/715 Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
• CPC Class Codes: A61K 36/483 Gleditsia (locust)
• CPC Class Codes: A61P 3/08 for glucose homeostasis pancreatic hormones A61P5/48
• CPC Class Codes: A61P 3/10 for hyperglycaemia, e.g. antidiabetics

Abstract

Pharmaceutical compositions comprising mixtures of xanthan gum and locust bean gum in a specified range of ratios have been found to exhibit synergistic effects in an in vitro test model. Pharmaceutical compositions adapted for oral administration comprising mixtures of xanthan gum and locust bean gum in the range of ratios are described for use in the treatment of diabetes or of satiety.

Claims

1. An oral pharmaceutical composition in dry powder or granular form adapted to be added to water or a drink for treatment of diabetes which comprises xanthan gum and locust bean gum in a weight:

weight ratio of between 1;

9 and 9;

1, 2.5 to 10% by weight of the composition of an alcohol soluble binding agent and 2.5 to 10% by weight of the composition of an organic acid.

2. A pharmaceutical composition according to claim 1 which comprises xanthan gum and locust bean gum in a weight:

weight ratio of between 1;

3 and 3;

1, 2.5 to 10% by weight of the composition of an alcohol soluble binding agent and 2.5 to 10% by weight of the composition of an organic acid.

3. A pharmaceutical composition according to claim 1 wherein the locust bean gum is a cold water dispersible locust bean gum.

4. A pharmaceutical composition according to claim 1 wherein the alcohol soluble binding agent is present at 5% by weight.

5. A pharmaceutical composition according to claim 1 wherein the alcohol soluble binding agent is polyvinylpyrrolidone.

6. A pharmaceutical composition according to claim 1 wherein the organic acid is citric acid or tartaric acid.

7. A pharmaceutical composition according to claim 1 in unit dose form and wherein the weight of the mixed gums is between 2 and 6 g.

8. A method of treating diabetes which comprises administering to a subject suffering from diabetes an orally effective amount of a pharmaceutical composition comprising xanthan gum and locust bean gum in a weight:

weight ratio of between 1;

9 and 9;

1 and 2.5 to 10% by weight of the composition of an alcohol soluble binding agent.

9. A method of treating diabetes which comprises administering to a subject suffering from diabetes an orally effective amount of a pharmaceutical composition comprising xanthan gum and locust bean gum in a weight:

weight ratio of between 1;

3 and 3;

1 and 2.5 to 10% by weight of the composition of an alcohol soluble binding agent.